SANUWAVE HEALTH INC (SNWV) Fundamental Analysis & Valuation

NASDAQ:SNWV • US80303D3052

Current stock price

20.2 USD
-0.32 (-1.56%)
At close:
20.2 USD
0 (0%)
After Hours:

This SNWV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SNWV Profitability Analysis

1.1 Basic Checks

  • SNWV had negative earnings in the past year.
  • SNWV had a positive operating cash flow in the past year.
  • SNWV had negative earnings in each of the past 5 years.
  • SNWV had negative operating cash flow in 4 of the past 5 years.
SNWV Yearly Net Income VS EBIT VS OCF VS FCFSNWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • SNWV has a Return On Assets (-19.79%) which is in line with its industry peers.
  • The Return On Invested Capital of SNWV (33.79%) is better than 99.47% of its industry peers.
Industry RankSector Rank
ROA -19.79%
ROE N/A
ROIC 33.79%
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNWV Yearly ROA, ROE, ROICSNWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • The Operating Margin of SNWV (16.60%) is better than 85.71% of its industry peers.
  • SNWV has a better Gross Margin (78.26%) than 91.53% of its industry peers.
  • In the last couple of years the Gross Margin of SNWV has grown nicely.
Industry RankSector Rank
OM 16.6%
PM (TTM) N/A
GM 78.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
SNWV Yearly Profit, Operating, Gross MarginsSNWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SNWV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNWV is creating value.
  • The number of shares outstanding for SNWV has been increased compared to 1 year ago.
  • Compared to 5 years ago, SNWV has more shares outstanding
  • The debt/assets ratio for SNWV has been reduced compared to a year ago.
SNWV Yearly Shares OutstandingSNWV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SNWV Yearly Total Debt VS Total AssetsSNWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • SNWV has an Altman-Z score of -5.07. This is a bad value and indicates that SNWV is not financially healthy and even has some risk of bankruptcy.
  • SNWV has a Altman-Z score of -5.07. This is in the lower half of the industry: SNWV underperforms 70.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.07
ROIC/WACC2.94
WACC11.5%
SNWV Yearly LT Debt VS Equity VS FCFSNWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

2.3 Liquidity

  • SNWV has a Current Ratio of 1.16. This is a normal value and indicates that SNWV is financially healthy and should not expect problems in meeting its short term obligations.
  • SNWV has a worse Current ratio (1.16) than 83.60% of its industry peers.
  • A Quick Ratio of 0.81 indicates that SNWV may have some problems paying its short term obligations.
  • SNWV's Quick ratio of 0.81 is on the low side compared to the rest of the industry. SNWV is outperformed by 83.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.81
SNWV Yearly Current Assets VS Current LiabilitesSNWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. SNWV Growth Analysis

3.1 Past

  • SNWV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -830.50%.
  • SNWV shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.89%.
  • SNWV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 99.64% yearly.
EPS 1Y (TTM)-830.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%117.4%
Revenue 1Y (TTM)40.89%
Revenue growth 3Y35.87%
Revenue growth 5Y99.64%
Sales Q2Q%22.34%

3.2 Future

  • Based on estimates for the next years, SNWV will show a very strong growth in Earnings Per Share. The EPS will grow by 31.48% on average per year.
  • SNWV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.94% yearly.
EPS Next Y106.17%
EPS Next 2Y46.14%
EPS Next 3Y31.48%
EPS Next 5YN/A
Revenue Next Year38.08%
Revenue Next 2Y34.58%
Revenue Next 3Y33.94%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SNWV Yearly Revenue VS EstimatesSNWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SNWV Yearly EPS VS EstimatesSNWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2025 2026 2027 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

3

4. SNWV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SNWV. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 21.18, SNWV is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, SNWV is valued a bit cheaper than the industry average as 76.72% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of SNWV to the average of the S&P500 Index (22.42), we can say SNWV is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 21.18
SNWV Price Earnings VS Forward Price EarningsSNWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNWV indicates a somewhat cheap valuation: SNWV is cheaper than 73.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.7
SNWV Per share dataSNWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SNWV's earnings are expected to grow with 31.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.14%
EPS Next 3Y31.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNWV Dividend Analysis

5.1 Amount

  • SNWV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNWV Fundamentals: All Metrics, Ratios and Statistics

SANUWAVE HEALTH INC

NASDAQ:SNWV (3/20/2026, 8:23:16 PM)

After market: 20.2 0 (0%)

20.2

-0.32 (-1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-19
Earnings (Next)05-07
Inst Owners56.18%
Inst Owner Change14.6%
Ins Owners1.33%
Ins Owner Change-0.86%
Market Cap173.32M
Revenue(TTM)41.28M
Net Income(TTM)-7.04M
Analysts82.5
Price Target55.08 (172.67%)
Short Float %7.01%
Short Ratio10.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.63%
Min EPS beat(2)-26.01%
Max EPS beat(2)111.27%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.18
P/S 4.2
P/FCF N/A
P/OCF 133.53
P/B N/A
P/tB N/A
EV/EBITDA 23.7
EPS(TTM)-0.93
EYN/A
EPS(NY)0.95
Fwd EY4.72%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.15
OCFY0.75%
SpS4.81
BVpS-0.34
TBVpS-1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.79%
ROE N/A
ROCE 42.77%
ROIC 33.79%
ROICexc 84.32%
ROICexgc N/A
OM 16.6%
PM (TTM) N/A
GM 78.26%
FCFM N/A
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
F-Score4
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 2.25
Cap/Depr 199.62%
Cap/Sales 5.04%
Interest Coverage 1.55
Cash Conversion 16.44%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.81
Altman-Z -5.07
F-Score4
WACC11.5%
ROIC/WACC2.94
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-830.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%117.4%
EPS Next Y106.17%
EPS Next 2Y46.14%
EPS Next 3Y31.48%
EPS Next 5YN/A
Revenue 1Y (TTM)40.89%
Revenue growth 3Y35.87%
Revenue growth 5Y99.64%
Sales Q2Q%22.34%
Revenue Next Year38.08%
Revenue Next 2Y34.58%
Revenue Next 3Y33.94%
Revenue Next 5YN/A
EBIT growth 1Y74.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year150.43%
EBIT Next 3Y67.94%
EBIT Next 5YN/A
FCF growth 1Y89.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.91%
OCF growth 3YN/A
OCF growth 5YN/A

SANUWAVE HEALTH INC / SNWV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SANUWAVE HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to SNWV.


Can you provide the valuation status for SANUWAVE HEALTH INC?

ChartMill assigns a valuation rating of 3 / 10 to SANUWAVE HEALTH INC (SNWV). This can be considered as Overvalued.


What is the profitability of SNWV stock?

SANUWAVE HEALTH INC (SNWV) has a profitability rating of 3 / 10.


What is the expected EPS growth for SANUWAVE HEALTH INC (SNWV) stock?

The Earnings per Share (EPS) of SANUWAVE HEALTH INC (SNWV) is expected to grow by 106.17% in the next year.